Abstract
Methodology: This prospective randomized control study was conducted at the tertiary health care centre of north India. After final diagnosis and considering inclusion and exclusion criteria one hundred and sixty one patients were enrolled in this study. Informed and written consent was taken from all the patients enrolled. Approval from institutional ethical committee was taken. Patients were divided into two groups. In-group I (standard group) patients were advised atorvastatin 10 mg once a day, metformin 500 mg twice a day, atenolol 50 mg once a day, amlodipine 5 mg once a day for a period of six weeks. In group II (Nigella sativa) group, patients were advised the above standard medication plus Nigella sativa oil 2.5 twice daily for a period of six weeks. Blood sugar both fasting and postprandial, fasting lipid profile and different parameters of obesity were recorded before therapy and after completion of therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
